Zobrazeno 1 - 10
of 45
pro vyhledávání: '"Juhani Kahri"'
Publikováno v:
Mediators of Inflammation, Vol 2006 (2006)
The study was aimed to compare inflammatory parameters between carriers of apoE4 isoforms (apoE4/3, apoE4/2, and apoE4/4 phenotypes) and those of carrying apoE3 isoform without apoE4 isoform (apoE3/3 phenotypes and apoE2/3 phenotypes). The concentrat
Externí odkaz:
https://doaj.org/article/0e71c75ae6ce48229e537b03518239e4
Autor:
Nina Lundbom, Linda Andersson, Sanni Söderlund, Juhani Kahri, Haihong Zhou, Martin Adiels, Marja-Riitta Taskinen, Annika Thorsell, Kirsi H. Pietiläinen, Antti Hakkarainen, Niina Matikainen, Elias Björnson, Carina Sihlbom, Chris J. Packard, Jan Borén
Publikováno v:
Diabetes, Obesity and Metabolism. 21:1861-1870
openaire: EC/H2020/305707/EU//RESOLVE Aims: To investigate how apolipoprotein C-III (apoC-III) metabolism is altered in subjects with type 2 diabetes, whether the perturbed plasma triglyceride concentrations in this condition are determined primarily
Autor:
Martin Adiels, Kimmo Porthan, Johannes Fuchs, Annika Thorsell, Niina Matikainen, Sanni Söderlund, Valentina Fermanelli, Jan Borén, Linda Andersson, Chris J. Packard, Antti Hakkarainen, Mari Ainola, Florian Kronenberg, Marja-Riitta Taskinen, Juhani Kahri, Nina Lundbom, Elias Björnson
Publikováno v:
Arteriosclerosis, thrombosis, and vascular biology. 41(2)
Objective: Increased risk of atherosclerotic cardiovascular disease in subjects with type 2 diabetes is linked to elevated levels of triglyceride-rich lipoproteins and their remnants. The metabolic effects of PCSK9 (proprotein convertase subtilisin/k
Autor:
Antti Hakkarainen, Linda Andersson, Carina Sihlbom, Sanni Söderlund, Martin Adiels, Juhani Kahri, Haihong Zhou, Jan Borén, Jesper Lundbom, Chris J. Packard, Elias Björnson, Niina Matikainen, Nina Lundbom, Marja-Riitta Taskinen, Annika Thorsell
Background: \ud Renewed interest in triglyceride-rich lipoproteins as causative agents in cardiovascular disease mandates further exploration of the integrated metabolism of chylomicrons and very low-density lipoproteins (VLDL).\ud \ud Methods: \ud N
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7c327bb5be2ea8e1e6ae4b480e8aaefc
https://eprints.gla.ac.uk/206966/1/206966.pdf
https://eprints.gla.ac.uk/206966/1/206966.pdf
Autor:
Jan Borén, Gerald F. Watts, Martin Adiels, Sanni Söderlund, Dick C. Chan, Antti Hakkarainen, Jesper Lundbom, Nina Lundbom, Niina Matikainen, Juhani Kahri, Bruno Vergès, P. Hugh R. Barrett, Marja-Riitta Taskinen
Publikováno v:
Arteriosclerosis, Thrombosis, and Vascular Biology. 35:2218-2224
Objectives— Patients with obesity and diabetes mellitus have increased risk of cardiovascular disease. A major cause is an atherogenic dyslipidemia related primarily to elevated plasma concentrations of triglyceride-rich lipoproteins. The aim of th
Autor:
Marja-Riitta Taskinen, Isabelle Simoneau-Robin, Sanni Söderlund, Antti Hakkarainen, Martin Adiels, Jan Borén, Dick C. Chan, P. H. R. Barrett, Niina Matikainen, Gerald F. Watts, Bruno Vergès, Laurence Duvillard, Juhani Kahri, Jesper Lundbom, Serge Aho, Nina Lundbom
Publikováno v:
Journal of Clinical Endocrinology and Metabolism
Journal of Clinical Endocrinology and Metabolism, Endocrine Society, 2016, 101 (4), pp.1398-1406. 〈http://press.endocrine.org/doi/10.1210/jc.2015-3740?url_ver=Z39.88-2003&rfr_id=ori%3Arid%3Acrossref.org&rfr_dat=cr_pub%3Dpubmed&〉. 〈10.1210/jc.2015-3740〉
Journal of Clinical Endocrinology and Metabolism, Endocrine Society, 2016, 101 (4), pp.1398-1406. 〈http://press.endocrine.org/doi/10.1210/jc.2015-3740?url_ver=Z39.88-2003&rfr_id=ori%3Arid%3Acrossref.org&rfr_dat=cr_pub%3Dpubmed&〉. 〈10.1210/jc.2015-3740〉
IF 5.531; International audience; Context: The metabolism of high-density lipoprotein (HDL) is severely impaired in individuals with abdominal obesity. However, the specific metabolism of apolipoprotein (apo)-A-II, the second major apolipoprotein of
Autor:
Nina Lundbom, Antti Hakkarainen, Martin Adiels, Marju Orho-Melander, Sanni Söderlund, Jan Borén, Jukka Westerbacka, Sven-Olof Olofsson, Jesper Lundbom, Juhani Kahri, Marja-Riitta Taskinen
Publikováno v:
Arteriosclerosis, Thrombosis, and Vascular Biology
Arteriosclerosis, Thrombosis, and Vascular Biology; Vol 31
Arteriosclerosis, Thrombosis, and Vascular Biology; Vol 31
Objective— Obesity increases the risk of cardiovascular disease and premature death. However, not all obese subjects develop the metabolic abnormalities associated with obesity. The aim of this study was to clarify the mechanisms that induce dyslip
Autor:
Mikko Syvänne, Seppo Sarna, T. Nakano, Marja-Riitta Taskinen, Marit Granér, Juhani Kahri, Markku S. Nieminen
Publikováno v:
University of Helsinki
Background Remnant lipoprotein particles (RLPs) and oxidative stress are components of postprandial state. We investigated the concentrations of triglyceride-rich lipoproteins (TRLs), RLPs, low-density lipoprotein (LDL) size, and oxidized LDL (oxLDL)
Autor:
Juhani Kahri, Markku S. Nieminen, Marit Granér, Marja-Riitta Taskinen, Mikko Syvänne, Richard W. James
Publikováno v:
Journal of the American College of Cardiology. 47:2429-2435
ObjectivesThe goal of this study was to examine the association between paraoxonase-1 (PON1) activity and concentration and the severity and extent of coronary artery disease (CAD).BackgroundParaoxonase-1, a high-density lipoprotein-associated enzyme
Publikováno v:
University of Helsinki
Mediators of Inflammation
Mediators of Inflammation, Vol 2006 (2006)
Mediators of Inflammation
Mediators of Inflammation, Vol 2006 (2006)
The study was aimed to compare inflammatory parameters between carriers of apoE4 isoforms (apoE4/3, apoE4/2, and apoE4/4 phenotypes) and those of carrying apoE3 isoform without apoE4 isoform (apoE3/3 phenotypes and apoE2/3 phenotypes). The concentrat